(Q36804414)

16 August 2017

1 reference

title

IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases (English)

1 reference

16 August 2017

Robert Sabat

1

1 reference

16 August 2017

Elizabeth Wallace

series ordinal

2

1 reference

16 August 2017

Stefanie Endesfelder

series ordinal

3

1 reference

16 August 2017

Kerstin Wolk

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Expert Opinion on Therapeutic Targets

16 August 2017

1 reference

16 August 2017

11

1 reference

16 August 2017

5

1 reference

16 August 2017

601-612

1 reference

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain

16 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Cutting edge: immune cells as sources and targets of the IL-10 family members?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Structural analysis of IL-10 and Type I interferon family members and their complexes with receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Structural features of the interleukin-10 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

The family of IL-10-related cytokines and their receptors: related, but to what extent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

IL-22 increases the innate immunity of tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Interleukin 20: discovery, receptor identification, and role in epidermal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Promoter analysis of interleukin 19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Crystal structure of interleukin-19 defines a new subfamily of helical cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Structural studies of the interleukin-19 subfamily of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

A2B adenosine receptors induce IL-19 from bronchial epithelial cells, resulting in TNF-alpha increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Bacterial endotoxin induces IL-20 expression in the glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Human fetal membrane expression of IL-19 and IL-20 and its differential effect on inflammatory cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Characterization of the Recombinant Extracellular Domains of Human Interleukin-20 Receptors and Their Complexes with Interleukin-19 and Interleukin-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

New drugs for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

Clinical Experience Acquired with Raptiva (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

The biology of TNF blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.601

10.1517/14728222.11.5.601

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference